CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹17,132 Cr | ₹17,765 Cr | ₹14,147 Cr | ₹11,772 Cr | ₹9,798 Cr |
What is the latest Net Current Assets ratio of CIPLA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹17,132 Cr |
| Mar2025 | ₹17,765 Cr |
| Mar2024 | ₹14,147 Cr |
| Mar2023 | ₹11,772 Cr |
| Mar2022 | ₹9,798 Cr |
How is Net Current Assets of CIPLA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,132 Cr | -3.56 | |
| Mar2025 | ₹17,765 Cr | 25.58 | |
| Mar2024 | ₹14,147 Cr | 20.17 | |
| Mar2023 | ₹11,772 Cr | 20.15 | |
| Mar2022 | ₹9,798 Cr | - | |
Compare Net Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹113,247.4 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹103,881.0 Cr | 2.9% | 2.2% | 1.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 3.2% |
5% |
-11.9% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses